KERANOVA announces the success of its first round of financing for 4 million euros, with an additional 1 million euro of support from Bpifrance. The potential of KERANOVA’s project was able to attract renowned investors active in life sciences. This funding envelope will enable the company to reach the clinical study phase required before new surgical equipment under development can be marketed.

Press Release